Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-09-09
1995-08-29
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 46, 514 49, 514 50, 514894, A61K 31505, A61K 3152
Patent
active
054460298
ABSTRACT:
Use of a compound of the formula ##STR1## wherein Base is thymine, Cytosine, adenine or guanine, or a physiologically acceptable salt thereof, for therapeutic treatment of hepatitis B virus infections and to a method for such treatment.
REFERENCES:
patent: 3775397 (1973-11-01), Etzold et al.
patent: 3817982 (1974-06-01), Verheyden et al.
patent: 4780453 (1988-10-01), Rideout et al.
patent: 4861759 (1989-08-01), Mitsuya et al.
patent: 4880782 (1989-11-01), Eckstein et al.
patent: 4963662 (1990-10-01), Matthes et al.
Fauci, Proc. Natl. Acad. Sci., vol. 83, pp. 9278-9283 (1986).
Mitsuya et al., "Protection of T. Cells . . . In Vitro," Retroviruses in Human Lymphoma/Leukemia, Japan Sci. Soc. Press (1985) pp. 277-288.
Sandstrom et al., "Antiviral Therapy in AIDS" Drugs vol. 34: pp. 372-390 (1987) AIDS Press Limited.
Kowollik et al., J. fur praktische Chemie, vol. 315, No. 5, pp. 895-900 (1973).
Herdewijn et al., J. Med. Chem., 30:1270-78 (1987).
Putkonen et al., Journal of Acquired Immune Deficiency Syndromes, vol. 2, pp. 359-365 (1989).
Oberg, Antiviral Therapy, IV Int'l. Conf. on AIDS, Stockholm 1988, J. Acquired Immune Deficiency Syndromes 1:257-266 (1988).
Lundgren et al., Inhibition of Early Occurence of Viral Antigen in SIV-Infected Macaques as a Measurement of Antiviral Efficacy (Manuscript 1989).
Wu et al., Antimicrob. Agent. and Chemother., vol. 32 No. 12, pp. 1887-1890 (Dec. 1988).
Antimicrob. Agents and Chemother., 32:1733-1734 (1988).
Kowollik et al., J. fur. praktische Chemie, vol. 315, No. 5, pp. 895-900 (1973).
Eriksson Bertil F. H.
Johansson Karl N. G.
Oberg Bo F.
Stening Goran B.
Medivir AB
Robinson Douglas W.
Wilson James O.
LandOfFree
Anti-retroviral activity of 2',3'-dideoxy-3'-fluoronucleosides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-retroviral activity of 2',3'-dideoxy-3'-fluoronucleosides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-retroviral activity of 2',3'-dideoxy-3'-fluoronucleosides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1819517